Literature DB >> 24492371

Phenethyl isothiocyanate inhibits shiga toxin production in enterohemorrhagic Escherichia coli by stringent response induction.

Dariusz Nowicki1, Monika Maciąg-Dorszyńska, Wioletta Kobiela, Anna Herman-Antosiewicz, Alicja Węgrzyn, Agnieszka Szalewska-Pałasz, Grzegorz Węgrzyn.   

Abstract

The pathogenicity of enterohemorrhagic Escherichia coli (EHEC) depends on production of Shiga toxins, which are encoded by stx genes located in the genomes of lambdoid prophages. Efficient expression of these genes requires prophage induction and lytic development of phages. Treatment of EHEC infections is problematic due to not only the resistance of various strains to antibiotics but also the fact that many antibiotics cause prophage induction, thus resulting in high-level expression of stx genes. Here we report that E. coli growth, Shiga toxin-converting phage development, and production of the toxin by EHEC are strongly inhibited by phenethyl isothiocyanate (PEITC). We demonstrate that PEITC induces the stringent response in E. coli that is mediated by massive production of a global regulator, guanosine tetraphosphate (ppGpp). The stringent response induction arises most probably from interactions of PEITC with amino acids and from amino acid deprivation-mediated activation of ppGpp synthesis. In mutants unable to synthesize ppGpp, development of Shiga toxin-converting phages and production of Shiga toxin are significantly enhanced. Therefore, ppGpp, which appears at high levels in bacterial cells after stimulation of its production by PEITC, is a negative regulator of EHEC virulence and at the same time efficiently inhibits bacterial growth. This is in contrast to stimulation of virulence of different bacteria by this nucleotide reported previously by others.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24492371      PMCID: PMC4023782          DOI: 10.1128/AAC.02515-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  63 in total

1.  Residual guanosine 3',5'-bispyrophosphate synthetic activity of relA null mutants can be eliminated by spoT null mutations.

Authors:  H Xiao; M Kalman; K Ikehara; S Zemel; G Glaser; M Cashel
Journal:  J Biol Chem       Date:  1991-03-25       Impact factor: 5.157

2.  Effects of fosfomycin on Shiga toxin-producing Escherichia coli: quantification of copy numbers of Shiga toxin-encoding genes and their expression levels using real-time PCR.

Authors:  Naoko Ichinohe; Yuko Ohara-Nemoto; Takayuki K Nemoto; Shigenobu Kimura; Sadato Ichinohe
Journal:  J Med Microbiol       Date:  2009-06-04       Impact factor: 2.472

3.  Simple method for plating Escherichia coli bacteriophages forming very small plaques or no plaques under standard conditions.

Authors:  Joanna M Loś; Piotr Golec; Grzegorz Wegrzyn; Alicja Wegrzyn; Marcin Loś
Journal:  Appl Environ Microbiol       Date:  2008-06-27       Impact factor: 4.792

Review 4.  (p)ppGpp: still magical?

Authors:  Katarzyna Potrykus; Michael Cashel
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

5.  Different classes of antibiotics differentially influence shiga toxin production.

Authors:  Colleen Marie McGannon; Cynthia Ann Fuller; Alison Ann Weiss
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

6.  Hydrogen peroxide-mediated induction of the Shiga toxin-converting lambdoid prophage ST2-8624 in Escherichia coli O157:H7.

Authors:  Joanna M Loś; Marcin Loś; Alicja Wegrzyn; Grzegorz Wegrzyn
Journal:  FEMS Immunol Med Microbiol       Date:  2009-12-10

Review 7.  Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections.

Authors:  Antonio Serna; Edgar C Boedeker
Journal:  Curr Opin Gastroenterol       Date:  2008-01       Impact factor: 3.287

8.  Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli.

Authors:  Theresa J Ochoa; Jane Chen; Christopher M Walker; Elsa Gonzales; Thomas G Cleary
Journal:  Antimicrob Agents Chemother       Date:  2007-05-25       Impact factor: 5.191

9.  The Escherichia coli K-12 "wild types" W3110 and MG1655 have an rph frameshift mutation that leads to pyrimidine starvation due to low pyrE expression levels.

Authors:  K F Jensen
Journal:  J Bacteriol       Date:  1993-06       Impact factor: 3.490

Review 10.  The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak.

Authors:  Helge Karch; Erick Denamur; Ulrich Dobrindt; B Brett Finlay; Regine Hengge; Ludgers Johannes; Eliora Z Ron; Tone Tønjum; Philippe J Sansonetti; Miguel Vicente
Journal:  EMBO Mol Med       Date:  2012-08-24       Impact factor: 12.137

View more
  10 in total

1.  Cinnamon Oil Inhibits Shiga Toxin Type 2 Phage Induction and Shiga Toxin Type 2 Production in Escherichia coli O157:H7.

Authors:  Lina Sheng; Barbara Rasco; Mei-Jun Zhu
Journal:  Appl Environ Microbiol       Date:  2016-10-27       Impact factor: 4.792

2.  Vitamin K Analogs Influence the Growth and Virulence Potential of Enterohemorrhagic Escherichia coli.

Authors:  Anne Kijewski; Ingun Lund Witsø; Hildegunn Iversen; Helene Thorsen Rønning; Trine L'Abée-Lund; Yngvild Wasteson; Toril Lindbäck; Marina Aspholm
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

3.  Different expression patterns of genes from the exo-xis region of bacteriophage λ and Shiga toxin-converting bacteriophage Ф24B following infection or prophage induction in Escherichia coli.

Authors:  Sylwia Bloch; Bożena Nejman-Faleńczyk; Aleksandra Dydecka; Joanna M Łoś; Agnieszka Felczykowska; Alicja Węgrzyn; Grzegorz Węgrzyn
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

4.  Isothiocyanates as effective agents against enterohemorrhagic Escherichia coli: insight to the mode of action.

Authors:  Dariusz Nowicki; Olga Rodzik; Anna Herman-Antosiewicz; Agnieszka Szalewska-Pałasz
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

5.  Relevance of Bacteriophage 933W in the Development of Hemolytic Uremic Syndrome (HUS).

Authors:  Manuel E Del Cogliano; Alipio Pinto; Jorge Goldstein; Elsa Zotta; Federico Ochoa; Romina Jimena Fernández-Brando; Maite Muniesa; Pablo D Ghiringhelli; Marina S Palermo; Leticia V Bentancor
Journal:  Front Microbiol       Date:  2018-12-13       Impact factor: 5.640

6.  Effect of Lactobacillus acidophilus Fermented Broths Enriched with Eruca sativa Seed Extracts on Intestinal Barrier and Inflammation in a Co-Culture System of an Enterohemorrhagic Escherichia coli and Human Intestinal Cells.

Authors:  Francesca Bonvicini; Eleonora Pagnotta; Angela Punzo; Donato Calabria; Patrizia Simoni; Mara Mirasoli; Nadia Passerini; Serena Bertoni; Luisa Ugolini; Luca Lazzeri; Giovanna Angela Gentilomi; Cristiana Caliceti; Aldo Roda
Journal:  Nutrients       Date:  2020-10-07       Impact factor: 5.717

7.  Induction of the Stringent Response Underlies the Antimicrobial Action of Aliphatic Isothiocyanates.

Authors:  Dariusz Nowicki; Klaudyna Krause; Patrycja Szamborska; Adrianna Żukowska; Grzegorz M Cech; Agnieszka Szalewska-Pałasz
Journal:  Front Microbiol       Date:  2021-01-14       Impact factor: 5.640

Review 8.  Prophage Activation in the Intestine: Insights Into Functions and Possible Applications.

Authors:  Jie Hu; Hao Ye; Shilan Wang; Junjun Wang; Dandan Han
Journal:  Front Microbiol       Date:  2021-12-13       Impact factor: 5.640

9.  Evaluation of the Anti-Shigellosis Activity of Dietary Isothiocyanates in Galleria mellonella Larvae.

Authors:  Dariusz Nowicki; Klaudyna Krause; Monika Karczewska; Agnieszka Szalewska-Pałasz
Journal:  Nutrients       Date:  2021-11-07       Impact factor: 5.717

10.  Various modes of action of dietary phytochemicals, sulforaphane and phenethyl isothiocyanate, on pathogenic bacteria.

Authors:  Dariusz Nowicki; Monika Maciąg-Dorszyńska; Krystyna Bogucka; Agnieszka Szalewska-Pałasz; Anna Herman-Antosiewicz
Journal:  Sci Rep       Date:  2019-09-23       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.